According to Prelude Therapeutics's latest financial reports the company's current revenue (TTM ) is A$4.86 Million. In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | A$4.33 M | |
2023 | N/A | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A |